MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
Introduction In this secondary analysis of the Metformin and AcaRbose in Chinese as the initial Hypoglycaemic treatment (MARCH) trial, we evaluated what demographic and clinical factors were associated with reduction in weight. We also assessed the effects of acarbose and metformin treatment on weig...
Saved in:
Main Authors: | Na Wang, Jin-Ping Zhang, Xiao-Yan Xing, Zhao-Jun Yang, Bo Zhang, Xin Wang, Wen-Ying Yang |
---|---|
Format: | article |
Language: | EN |
Published: |
Termedia Publishing House
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/f47e2d59273c4b97bcd307641ba863bb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome
by: Nielson T. Baxter, et al.
Published: (2019) -
Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes
by: Song L, et al.
Published: (2021) -
A Combination Approach in Inhibiting Type 2 Diabetes-Related Enzymes Using <i>Ecklonia radiata</i> Fucoidan and Acarbose
by: Blessing Mabate, et al.
Published: (2021) -
Metformin action over gut microbiota is related to weight and glycemic control in gestational diabetes mellitus: A randomized trial
by: María Molina-Vega, et al.
Published: (2022) -
Principles of Rapid Weight Loss in Female Sambo Athletes
by: Nikola Todorović, et al.
Published: (2021)